Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025241 | PMC |
| http://dx.doi.org/10.1308/003588410x12628812459490 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Optimizing G-CSF outpatient prescriptions: beyond clinical indications-a survey analysis.
Support Care Cancer
January 2025
Army Medical University, Chongqing, 400037, China.
Thyroid Nodule Ablation: Ever Expanding Indications.
Radiol Imaging Cancer
January 2025
From the Division of Interventional Radiology, Beth Israel Deaconess Medical Center-Harvard Medical School, 1 Deaconess Rd, Rosenberg 3, Boston, MA 02215.
Role of locoregional therapy including liver transplantation in liver-only metastatic colorectal cancer: a review paper.
Expert Rev Anticancer Ther
January 2025
Department of Medical Oncology, The Queen Elizabeth Hospital, Woodville, SA, Australia.
Introduction: Resection of primary tumor and liver metastases is the gold standard for colorectal cancer with liver-only metastases (CRLM). Although treatment options have expanded to enable conversion of unresectable to resectable CRLM, about 40% of patients will have definitively unresectable disease. Major advances in surgical techniques, immunosuppressive protocols and patient selection criteria for liver transplantation have resulted in improved outcomes.
View Article and Find Full Text PDFReconsideration of the clinical management of hepatic hemangioma.
World J Gastrointest Surg
November 2024
Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
Article Synopsis
- * The proposed grading system aims to enhance clinical management, especially for patients who experience symptoms or complications.
- * The authors review existing literature on surgical indications and treatments for hepatic hemangioma to evaluate the effectiveness of the new grading system.
Inflammatory, Hematological, and Biochemical Biomarkers in COVID-19 Patients.
Immun Inflamm Dis
December 2024
Department of Pathology, Moi University, Eldoret, Kenya.
Introduction: There are few accurate prognostic indications of the illness's development and severity for COVID-19, despite certain biomarkers having been investigated. The unexpected nature of COVID-19's course, which can quickly progress from asymptomatic to life-threatening symptoms, lies at the heart of the disease's intricacy. Predicting SARS-CoV-2 pathogenicity through laboratory biomarkers and as such, identifying the patients' illness severity at the time of their initial admission would be crucial in improving patient care.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!